Heartflow, Inc. (HTFL)
Heartflow, Inc. (HTFL) is a healthcare company (health information services) based in the United States. The share price is $47.38, up 1.11% on the day, which values the company at $4.16B. Price as of 17 Nov 2026, 17:14 UTC, from Yahoo Finance.
Key facts
- Share price
- $47.38+1.11% today
- Market value
- $4.16B
- P/E ratio
- 70.7×last 12 months
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Heartflow, Inc. in more detail
HTFL trades at 70.7× its last twelve months' earnings, -178.7× next year's expected earnings, 17.4× sales.
In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Beneish M-score flags the accounts; Thin interest cover.
3 of the superinvestors tracked here hold HTFL, including Ron Baron (0.2% of the portfolio), Polen Capital team (0.0% of the portfolio), Temasek (0.0% of the portfolio).
Superinvestors holding HTFL
3 of the investors tracked here report a position in their latest 13F filing.
- Ron Baron Baron Capital (BAMCO)0.21% of portfolio · $124.9M · trimmed · Q3 2026
- Polen Capital team Polen Capital Management0.03% of portfolio · $2.9M · new · Q3 2026
- Temasek Temasek Holdings0.03% of portfolio · $10M · added · Q3 2026
Health Care companies of similar size
- Merit Medical SystemsMMSI
- Edgewise TherapeuticsEWTX
- LivaNovaLIVN
- Ionis PharmaceuticalsIONS
- Dianthus TherapeuticsDNTH
- MiniMed GroupMMED
- Adaptive BiotechnologiesADPT
- CRISPR TherapeuticsCRSP
- Travere TherapeuticsTVTX
- Option Care HealthOPCH
- Legend BiotechLEGN
- Definium TherapeuticsDFTX
Side by side:HTFL vs CRSP (Heartflow, Inc. vs CRISPR Therapeutics)HTFL vs ADPT (Heartflow, Inc. vs Adaptive Biotechnologies)HTFL vs TVTX (Heartflow, Inc. vs Travere Therapeutics)HTFL vs MMED (Heartflow, Inc. vs MiniMed Group)HTFL vs DNTH (Heartflow, Inc. vs Dianthus Therapeutics)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Heartflow, Inc. (HTFL): questions and answers
What is HTFL's P/E ratio?
Heartflow, Inc. trades at 70.7× its last twelve months' earnings and -178.7× next year's expected earnings.
What is Heartflow, Inc.'s market cap?
Heartflow, Inc. is valued at $4.16B at a share price of $47.38.
Does HTFL pay a dividend?
Heartflow, Inc. does not currently pay a regular dividend.
Which famous investors own HTFL?
In their latest quarterly filings, Ron Baron (0.2% of the portfolio), Polen Capital team (0.0% of the portfolio), Temasek (0.0% of the portfolio) hold HTFL. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Heartflow, Inc. (HTFL) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/HTFL
Underlying data: Yahoo Finance; company filings with the SEC.